More people affected by memory diseases in aging society

As the population ages, more people are affected by memory diseases like Alzheimer's. However, research in the field is progressing slowly, and only about half of those affected receive the available treatment.

In an opinion piece in Dagens Nyheter, Lisa Magnusson questions how pleasant the final years of life will truly be for many elderly people. She notes that as lifespans increase, more individuals are affected by memory diseases. Despite this, research in the area is advancing slowly.

The article states that only about half of those suffering from Alzheimer's receive the treatment that is actually available. This raises concerns about how society addresses the rising prevalence of these conditions. Magnusson emphasizes the need for better support and progress in healthcare to ensure a dignified old age.

The piece was published on January 10, 2026, and is part of DN's editorial page, focusing on debate and reflection on societal issues.

관련 기사

Diverse young adults reviewing charts on rising cognitive disabilities in a community setting, illustrating a Neurology study on surges among under-40s due to social and economic factors.
AI에 의해 생성된 이미지

Self-reported cognitive disabilities surge among young U.S. adults

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

A peer-reviewed Neurology study finds a sharp rise in self-reported cognitive difficulties among U.S. adults from 2013 to 2023, with rates nearly doubling in people under 40 and the steepest increases among lower-income and less-educated groups. Authors point to social and economic factors and call for further study.

A recently recognized form of dementia, known as LATE, is reshaping understanding of cognitive decline in the elderly, with rising diagnoses and guidelines for doctors published this year. It is estimated to affect about one-third of people aged 85 or older and 10% of those aged 65 or older, often mistaken for Alzheimer's. Experts emphasize the need for a broader range of treatments for this condition.

AI에 의해 보고됨

알츠하이머 시험이 암 연구에서 영감을 받은 다중 표적 접근으로 전환 중이며, Novo Nordisk의 세마글루타이드 실패에도 불구하고. Eli Lilly의 Kisunla와 Eisai 및 Biogen의 Leqembi 두 약물만이 진행을 늦추기 위해 널리 승인됨. 이러한 진화는 뇌 퇴화 질환을 복잡한 시스템으로 간주하며, 전 세계적 영향 속에서 이를 멈추는 새로운 방법을 모색함.

A new study reveals that despite guidelines, about one in four Medicare beneficiaries with dementia continue to receive brain-altering medications linked to falls and confusion. Prescribing rates have declined overall from 20% to 16% between 2013 and 2021, but those with cognitive impairment face higher risks. Researchers highlight the need for better documentation and alternatives to improve care safety.

AI에 의해 보고됨

Elderly and social insurance minister Anna Tenje (M) has criticized Borås for cutting back on food for the elderly while investing in the zoo. Municipal council chairman Ulf Olsson rejects the accusations, emphasizing that no savings have been made on food quality. The debate arose in a radio broadcast about rising food prices in elderly care.

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

AI에 의해 보고됨 사실 확인됨

A Lancet analysis estimates that nearly 800 million adults were living with chronic kidney disease in 2023—up from 378 million in 1990—with the illness now ranking ninth among global causes of death. Researchers urge earlier detection and wider access to proven treatments.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부